Roche Holding AG

RHHBY

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,249

Roche Holding AG News & Analysis

stocks

10 best US blue-chip stocks to buy for the long term

The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks

The 10 best global companies to invest in now

These undervalued stocks of high-quality companies are attractive investments today.
stocks

5 top US dividend shares from the best managers

These cheap dividend stocks are popular among highly rated concentrated fund managers.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,264.308.500.09%
CAC 408,045.353.990.05%
DAX 4024,618.146.890.03%
Dow JONES (US)46,358.42243.36-0.52%
FTSE 1009,507.571.83-0.02%
HKSE26,290.32462.27-1.73%
NASDAQ23,024.6318.75-0.08%
Nikkei 22548,088.80491.64-1.01%
NZX 50 Index13,467.26103.60-0.76%
S&P 5006,735.1118.61-0.28%
S&P/ASX 2008,958.309.200.10%
SSE Composite Index3,897.0336.94-0.94%

Market Movers